Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:13:07 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Global Hemp Group Inc (2)
Symbol GHG
Shares Issued 21,291,458
Close 2024-01-31 C$ 0.05
Market Cap C$ 1,064,573
Recent Sedar+ Documents

Global Hemp issues three million units for debt

2024-01-31 18:18 ET - News Release

Subject: please disseminate Word Document File: '\\swfile\EmailIn\20240131 150424 Attachment 2024 Jan 31 - GHG Annouces Closing of Debt Settlement.docx' CSE: GHG FF: GHG OTC: GBHPF #106 - 1169 Mt. Seymour Rd, North Vancouver, BC V7H 2Y4 Tel: 778-726-2900 EM: info@globalhempgroup.com Global Hemp Group Announces Closing of Debt Settlement Vancouver, BC -- (January 31, 2024) -- GLOBAL HEMP GROUP INC. ("GHG" or the "Company") (CSE: GHG / OTCQB: GBHPF / FRANKFURT: GHG) Further to the Company's news release of January 15, 2024, the Company has issued an aggregate of 3 million units at a price of $0.05 per unit to settle $150,000 of its outstanding long term unsecured debt, due March 8, 2025. Each Unit is comprised of one common share in the capital of the Company (each a "Common Share") and one non-transferable Common Share purchase warrant (each a "Warrant"). Each Warrant entitles the holder to acquire one Common Share at a price of $0.10 per share, exercisable until January 15, 2027. The remaining balance of $300,000 plus accrued interest at 12% per annum, will continue to accrue interest until maturity on March 8, 2025, if not converted prior to maturity into units with the same terms and conditions as the above referenced initial debt settlement amount. All securities issued and issuable in connection with this debt settlement are subject to a statutory hold period of four months and one day, expiring on June 1, 2024. No finder's fees were paid in connection with this transaction. About Global Hemp Group Inc. Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is a dynamic company currently focused on two key business segments - Industrial Hemp and Biopharma. The Industrial Hemp division's primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. Our R&D team is engaged in developing Intellectual Property that can be patented and implemented within our projects and beyond. The Health and Wellness Division is focused on the acquisition of exclusive patents and IP through licensing agreements. The Company acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms. More recently, the Company has signed a Letter of Intent with B-Organic R&D Corp. relating to the use of their Bioactive Lipid Agents ("BLA") technology with cannabinoids, terpenes, flavonoids and mushroom extracts. BLA enhances the solubility and bioavailability of various "poorly soluble pharma ingredients". These strategic alliances form the basis for the commercialization of promising independently pre-clinically tested formulations, underscoring our commitment to cutting-edge innovation in the commercial biopharma sector. For Further Information Contact Global Hemp Group Investor Relations Tel: 778-726-2900 info@globalhempgroup.com www.globalhempgroup.com Cautionary Note Regarding Forward Looking Statements Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise. The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

© 2026 Canjex Publishing Ltd. All rights reserved.